本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

19.26
+0.85004.62%
盤後19.500.2400+1.25%17:09 EDT
成交量:372.98萬
成交額:7,162.66萬
市值:54.34億
市盈率:-5.99
高:19.56
開:18.59
低:18.59
收:18.41
52周最高:42.50
52周最低:17.15
股本:2.82億
流通股本:9,191.75萬
量比:0.99
換手率:4.06%
股息:- -
股息率:- -
每股收益(TTM):-3.2173
每股收益(LYR):-3.2200
淨資產收益率:-45.37%
總資產收益率:3.84%
市淨率:9.41
市盈率(LYR):-5.98

資料載入中...

2026/03/04

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/30

重要事件披露

Form 8-K - Current report
2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/06/14

SEC問詢函

Form CORRESP - Correspondence
2025/06/14

SEC問詢函

Form CORRESP - Correspondence
2025/06/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/24

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/29

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/21

重要事件披露

8-K - Current report
2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership